SCHEMBL25015709

SCHEMBL25015709

N=C(N)c1ccc2cc(C(=O)Nc3ccc(CN4CCCC4)cc3)n(Cc3ccc(C(N)=O)cc3)c2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLAU P00749 5/20 0.49
▸ PLG P00747 4/20 0.49
▸ KLKB1 P03952 4/20 0.49
▸ PRSS1 P07477 4/20 0.49
▸ F2 P00734 3/20 0.49
▸ F10 P00742 6/20 0.46
▸ PLAT P00750 3/20 0.46
▸ HPGD P15428 1/20 0.46
▸ TNF P01375 1/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ RAB9A P51151 2/20 0.45
▸ LMNA P02545 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ HTR2C P28335 1/20 0.44
▸ MCHR1 Q99705 1/20 0.44
▸ NPC1 O15118 1/20 0.43
▸ HRH3 Q9Y5N1 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25015851 0.91 PLG (0.47) PLAUPLGKLKB1PRSS1F2
SCHEMBL25017267 0.91 PRSS1 (0.47) PLAUPLGKLKB1PRSS1F2
SCHEMBL25015847 0.90 PLG (0.47) PLAUPLGKLKB1PRSS1F2
SCHEMBL25017317 0.89 PRSS1 (0.47) PLAUPLGKLKB1PRSS1F2
SCHEMBL25015845 0.88 F10 (0.55) PLAUPLGKLKB1PRSS1F2
SCHEMBL21822169 0.87 MAPT (0.52) PLAUPLGKLKB1PRSS1F2
SCHEMBL25015710 0.85 KCNQ3 (0.46) PLAUPLGKLKB1PRSS1F2
SCHEMBL25016725 0.85 F10 (0.44) PLAUPLGKLKB1PRSS1F2
SCHEMBL25015697 0.85 ECE1 (0.42) PLAUPLGKLKB1PRSS1F2
SCHEMBL25016773 0.84 PLG (0.47) PLAUPLGKLKB1PRSS1F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230043159-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF DISC MEDICINE, INC. 2023-02-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230043159-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF MMP7, MATR3, SPINT2 PLAU 93/4885PLG 225/4885KLKB1 149/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback